Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases

Hellenic Journal of Nuclear Medicine

Volumn 9, Issue 1, 2006, Pages 5-9

  Hubalewska Dydejczyk, Alicja ^a   Sowa Staszczak, Anna ^a   Huszno, Bohdan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

99mTc nanocolloid; Blue dye technique; Lymphoscintigraphy; Sentinel node

Indexed keywords

ALBUMIN TC 99M; ISOSULFAN BLUE; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M; TECHNETIUM TIN COLLOID TC 99M;

BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY CANCER; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LAPAROSCOPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MEDIASTINUM LYMPH NODE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING; UTERINE CERVIX CANCER; VULVA CANCER;

BREAST NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 33646033016     PISSN: 11081430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Virchow R. Die krankhaften Geschwulste. 1963 Berlin, August Hirschwald.
2. Rik Pijpers Sentinel node imaging and detection in melanoma and breast cancer. Badhovedorp 1999, Rik Pijpers.
3. McBride CM. The surgeon as oncologist. South Med J 1978; 71: 1331-1333.
4. Liotta LA, Stetler-Stevenson WG. Principles of molecullar cell biology of cancer: cancer metastasis. In: Hellman S, Rosenberg SA, (eds). Cancer-Principles practice of oncology. 3rd edn. Philadelphia Lippincott; 1989: 98-115.
5. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg 1984; 119: 1067-1072.
6. Wallace S, Jackson L, Schaffer B, et al. Lymphangiograms: their diagnostic and therapeutic potential. Radiology 1961; 76: 179-199.
7. Hulten L, Rosencrantz M. Lymphangio-adenography in carcinoma of the breast. Acta Chir Scand 1966; 132: 261-274.
8. Moskovic E, Fernando I, Bake P, et al. Lymphography - current role in oncology. Br J Radiol 1991; 64: 422-427.
9. Stomper PC. Evaluation of lymph node metastases. In: Stomper PC. Cancer imaging manual. 1st edn. Philadelphia: Lippincott 1993; 51-60.
10. Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. JAMA 1997; 278: 1096-1101.
11. Atula TS, Varpula MJ, Kurki TJ, et al. Assessment of cervical lymph node status in head and neck cancer patients: palpation, CT and low field MRI compared with ultrasound-guided fine - needle aspiration cytology. Eur J Radiol 1997; 25: 152-161.
12. Arita AT, Matsumoto T, Kuramitsu T, et al. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, TEE, and nodal specimen. Chest 1996, 110: 1004-1008.
13. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998; 207: 123-130.
14. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
15. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
16. Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probe - guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2: 303-308.
17. Krag DN, Meijer S, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654-658.
18. Koops HS, Doting MH, de Vries J, et al. Sentinel node biopsy as a surgical staging method for solid cancer. Radiother Oncol 1999; 51: 1-7.
19. Krynyckyi BR, Zhang ZY, Kim CK, et al. Effect of high specific-activity sulfur colloid preparations on sentinel node count rates. Clin Nucl Med 2002; 27: 92-95.
20. Valdes Olmos RA, Jansen L, Muller SH, et al. Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology. Rev Esp Med Nucl 1999; 18: 111-121.
21. Chicken DW, Keshtgar MRS. The emerging role and implications of sentinel node biopsy in breast carcinoma. Hell J Nucl Med 2004; 7: 32-39.
22. Valdes Olmos RA, Hoefnagel CA, Nieweg OE, et al. Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med 1999; 26(4 Suppl): S2-S10.
23. Levenback C, Burke TW, Morris M, et al. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59: 216-220.
24. DeCesare SL, Fiorica JV, Roberts WS, et al. Intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997; 66: 28-54.
25. Terada KY, Coel MN, Ko P, et al. Combined use of intraoperative lymphatic mapping and lymphoscintigraphy in the management of squamous cell cancer of the vulva. Gynecol Oncol 1998; 70: 65-69.
26. Malur S, Krause N, Kohler C, et al. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 2001; 80: 254-257.
27. Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002; 20: 688-693.
28. Medl M, Peters-Engl C, Schutz P, et al. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 2000; 20: 1133-1134.
29. Lantzsch T, Wolters M, Grimm J, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 2001; 85: 791-794.
30. Rhim CC, Park JS, Bae SLN, et al. Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci 2002; 17: 507-511.
31. Verheijen RH, Pijpers R, van Diest PJ, et al. Sentinel node detection in cervical cancer. Obstet Gynecol 2000; 96: 135-138.
32. Hauspy J, Verkinderen L, De Pooter C, et al. Sentinel node metastasis in the groin detected by technetium-labeled nanocolloid in a patient with cervical cancer. Gynecol Oncol 2002; 86: 358-360.
33. Terada KY, Shimizu DM, Wong JH, et al. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000; 76: 40-44.
34. Rob L, Strnad P, Robova H, et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol 2005; 98: 281-288.
35. Silva LB, Silva-Filho AL, Traiman P, et al. Sentinel node detection in cervical cancer with 99mTc-phytate. Gynecol Oncol 2005; 97: 588-595.
36. Gil-Moreno A, Diaz-Feijoo B, Roca I, et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 2005; 96: 187-193.
37. 99mTc-Evans blue: five years of preclinical and human studies. Proceedings of the 3rd International Meeting of Nuclear Medicine of Northern Greece, 4-6 November 2005, Thessaloniki, Macedonia, Greece, edn of Hell Soc Nucl Med 2005; p 27, www.nuclmed.gr.
38. Reintgen D, Balch CM, Kirkwood J, et al. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997; 225: 1-14.
39. Stehman FB, Bundy BN, Dvoretsky PM, et al. Early stage I carcinoma of the vulva treated vath ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the gynecologic oncology goup. Obstet Gynecol 1992; 79: 490-497.
40. Kuhn JA, McCarty TM. Malignant melanoma and the sentinel lymph node biopsy. Cancer Invest 1999; 17: 39-46.
41. Tamussino KF, Bader AA, Lax SF, et al. Groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol Oncol 2002; 86: 99-101.
42. Angioli R, Palaia I, Cipriani C, et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 2005; 96: 504-509.
43. Lavenback C. Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications. Recent Results Cancer Res 2000; 157: 150-158.
44. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.
45. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-1717.
46. Bollen ECM, van Duin CJ, Theunissen PH, et al. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 1993; 55: 961-966.
47. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as by postsurgical pathologic staging. Cancer 1990; 65: 2503-2506.
48. Little AG, DeHoyos A, Kirgan DM, et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999; 117: 220-224.
49. Liptay MJ, Masters GA, Winchester DJ, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000; 70: 384-390.
50. Nomori H, Horio H, Naruke T, et al. Use of 99m technetium tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg 2002; 124: 486-492.
51. Sugi K, Fukuda M, Nakamura H, et al. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical NO lung cancer. Lung Cancer 2003; 39: 37-40.
52. Fry WA, Siddiqui A, Pensler JM, et al. Thoracoscopic implantation of cancer vath a fatal outcome. Ann Thorac Surg 1995; 59: 42-45.
53. Grondin SC, Liptay MJ. Current concepts in the staging of non-small cell lung cancer. Surg Oncol 2002; 11: 181-190.
54. Hubalewska A, Sowa-Staszczak A, Huszno B, et al. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer. Nucl Med Rev Cent East Eur 2003; 6: 127-130.